A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19)
- Conditions
- COVID-19
- Registration Number
- ITMCTR2000003144
- Lead Sponsor
- Guangzhou Eighth People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who have been diagnosed as COVID-19 according to The Diagnosis and Treatment Plan for 2019-nCoV(The Fifth Trial Edition);
2. aged between 18 to 80 years old, male or female;
3. the subjects participating the clinical trial are voluntary and sign the informed consent, thoroughly informed the purpose, method, possible reaction.
1. Patients who are difficult to be administered orally or by nasal feeding, those who are allergic to the test drug and those who are intolerant to the drug;
2. The compliance of medication cannot be guaranteed during the treatment
3. Patients with severe primary respiratory diseases, or pneumonia caused by other pathogen.
4. Patients with serious diseases, malignant tumors or mental diseases;
5. Pregnant women, urine pregnancy test positive;
6. Participated in other drug trials in the past month;
7. The investigator judged that the patient was not suitable for the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nucleic acid of nCoV-19;syndrome;
- Secondary Outcome Measures
Name Time Method lung CT;cardiac enzymes;liver and kidney function;blood count;